Life sciences companies are leveraging digitalization, new and evolving technologies, and third-party providers to boost innovation, quality, and speed.
These compelling advances also introduce cybersecurity vulnerabilities. Recent failures within companies and their third-party providers have led to significant and mounting harms. As an essential constituent of technology and business strategy, threats and risks must be evaluated and managed.
Understanding current and emerging cybersecurity threats and risks and how to deal with them is critical to the protection of intellectual properties, data, and patient privacy, and to continuous regulatory compliance.
Fill out the form to access the full-length webinar.
Here is a sampling of what Roger and Dom shared in this webinar.
About the Presenters
Roger Davy, Director, Customer Engagement
Dom Glavach, Chief Security Officer and Chief Security Strategist, CyberSN